Dementia Matters

As an individual develops dementia, they may need support in many areas of their lives. One of these areas is decision-making, particularly regarding health care decisions, but how can someone or their loved one determine if they need support with decision-making? To answer these questions, Dr. Victoria Williams joins to discuss capacity and capacity testing. She dives into the different kinds of decision-making abilities that can be assessed, the signs that one may need an assessment and more, as well as shares a preview of her upcoming Healthy Living with Mild Cognitive Impairment (MCI) program, “Cognitive Testing and Brain Imaging Explained.” Guest: Victoria Williams, PhD, neuropsychologist, UW Health, assistant professor, Department of Medicine, University of Wisconsin School of Medicine and Public Health Show Notes Register and learn more about Dr. Williams’ upcoming Healthy Living with MCI event, happening on September 12, 2025, and future programs on our website. Learn more about Dr. Williams at her bi

Receiving a diagnosis of mild cognitive impairment (MCI) or dementia can be an emotional and challenging experience. How can meditative practices support those living with MCI? Buddhist chaplain Sharon Lukert wrote her book, Until My Memory Fails Me, with the goal of sharing mindfulness and spiritual practices that have helped her since being diagnosed with MCI in 2021. She joins the podcast to share how her spirituality has impacted her journey to a diagnosis as well as strategies on navigating emotional struggles and building community for those living with MCI. Guest: Sharon Lukert, author, Buddhist chaplain Show Notes Learn more about Sharon Lukert and her book, Until My Memory Fails Me, on her website. Register for the Wisconsin ADRC’s Healthy Living with Mild Cognitive Impairment education series on our website. Learn about the Wisconsin ADRC’s involvement in the development of new blood tests, mentioned by Mrs. Lukert at 12:50, on our website. Interested in hearing more about what it’s like being invol

Frontotemporal lobar degeneration (FTLD) is one of the most common causes of dementia in individuals under the age of 60, yet it remains lesser known and often misunderstood. From the early symptoms to the challenges of diagnosis and treatment, FTLD presents unique hurdles for clinicians, researchers and families alike. Joining the podcast to discuss this complex disease is Dr. Brad Boeve, principal investigator of the ALLFTD study, a major national research effort aimed at identifying biomarkers and clinical tools to improve early detection of FTLD and prepare for future treatment trials.  Guest: Brad Boeve, MD, neurologist, Department of Neurology and Center for Sleep Medicine, professor of neurology, Division of Behavioral Neurology, Mayo Clinic, co-director, Mayo Clinic Alzheimer’s Disease Research Center, principal investigator, ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research study Show Notes Are you a clinician interested in receiving continuing education (CE) credits for

Smartphones and technology are ubiquitous in nearly every aspect of our lives, but is technology helping or hurting us when it comes to memory and cognition? Dr. Jared Benge, neuropsychologist and associate professor from the University of Texas at Austin, joins the podcast to discuss his research into how technology and smartphone use impacts the brain, how digital technology can be used to help individuals with cognitive impairment and what his findings mean for the future. Guest: Jared Benge, PhD, ABPP, clinical neuropsychologist, Comprehensive Memory Center, UT Health Austin, associate professor, Dell Medical School, University of Texas at Austin   Show Notes Read Dr. Benge’s article, “A meta-analysis of technology use and cognitive aging,” on the journal Nature’s website. Learn more about Dr. Benge at his profile on UT Health Austin’s website. Read Dr. Benge’s study on the use of smartphone technology to improve prospective memory functioning at the Journal of American Geriatrics Society. Dementia Matter

What is the current impact of Alzheimer’s disease and related dementias on the United States? To best understand its significance in 2025, we can turn to the Alzheimer’s Association’s Alzheimer’s Disease Facts and Figures report, a comprehensive resource that highlights the effect of Alzheimer’s on individuals, care partners, health care professionals and more. Dr. Heather Snyder from the Alzheimer’s Association joins the podcast to discuss key trends and findings from this year’s report, including insights from their special report on Americans’ attitudes toward early detection and new monoclonal antibody treatments. Guest: Heather Snyder, PhD, senior vice president, medical & scientific relations, Alzheimer’s Association Show Notes Read the 2025 Alzheimer’s Disease Facts and Figures report and special report from the Alzheimer’s Association on their website. Download and print the 2025 Alzheimer’s Disease Facts and Figures infographic on their website. Read about Dr. Snyder on her profile on the Alzheim

How much does it cost to live with dementia in the United States? The hidden costs are often overlooked, but these numbers and trends are important to understand in order to inform the public and effectively allocate resources. Dr. Julie Zissimopoulos leads The United States Cost of Dementia Project, where they recently published a report on the total cost of dementia in 2025. Dr. Zissimopoulos joins the podcast to discuss the report’s findings and analyze what this means for patients and families, as well as for public policy, in the future. Guest: Julie Zissimopoulos, PhD, professor, Sol Price School of Public Policy, University of Southern California (USC), co-lead, United States Cost of Dementia Project, co-director, Aging and Cognition Research Program, USC Schaeffer Center, director, Alzheimer’s Disease and Alzheimer’s Disease Related Dementias Resource Center for Minority Aging Research (USC AD/ADRDRCMAR), Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Demen

Everyone has habits. Some are beneficial for brain health while others are less so, but it turns out that habits as simple as brushing your teeth at the same time each morning can help your brain adapt to changes from cognitive impairment. Dr. Gordon Giles joins the podcast to dive into the fascinating world of neurological rehabilitation and how building small, consistent habits can rewire the brain and support healthy lifestyle choices. He also gives a sneak peek into his upcoming talk for the Healthy Living with Mild Cognitive Impairment (MCI) program titled “Unlocking the Power of Habits, Routines and Strategies.” Guest: Gordon Giles, PhD, OTR/L FAOTA, professor emeritus, Samuel Merritt University Show Notes Learn more about Dr. Giles at his profile on the Samuel Merritt University website. Register and learn more about Dr. Giles’ upcoming Healthy Living with MCI event, happening on June 20, 2025, and future programs on our website. Connect with us Find transcripts and more at our website. Email Dementia

It’s estimated that 4.3 million older adults across the United States live alone with cognitive impairment. How do these individuals navigate the challenges and concerns that arise due to these memory and thinking changes, and what recommendations are there to support them as they continue living independently? Dr. Elena Portacolone joins Dementia Matters to discuss her research focused on identifying these challenges and developing equitable policies and programs for older adults living alone with cognitive impairment in the United States and worldwide. Guest: Elena Portacolone, PhD, MBA, MPH, principal investigator, Living Alone with Cognitive Impairment Project, professor of sociology, Institute for Health & Aging, Pepper Center Scholar, Division of Geriatric Medicine, University of California San Francisco (UCSF) Show Notes Read more about Dr. Portacolone and her work at her profile on UCSF’s website. Learn more about UCSF’s Living Alone with Cognitive Impairment project, led by Dr. Portacolone, on th

How important is one’s family history when determining Alzheimer’s risk? Returning guests Drs. Jessica Langbaum and Sterling Johnson discuss the latest research on family history and genetic risk factors and share their perspectives on the topic, specifically focusing on the role of the APOE gene as a risk factor. Guests: Sterling Johnson, PhD, leader, Wisconsin Registry for Alzheimer’s Prevention (WRAP), associate director, Wisconsin Alzheimer’s Disease Research Center, associate director, Wisconsin Alzheimer’s Institute, lead principal investigator, ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI), Jean R. Finley Professor of Geriatrics and Dementia, UW School of Medicine and Public Health, and Jessica Langbaum, PhD, senior director of research strategy, Banner Alzheimer’s Institute, overseer, Observational Research Program, Clinical Trials Program, Alzheimer’s Prevention Initiative, director, Alzheimer’s Prevention Registry, director, Arizona Alzheimer’s Disease Research Center Show N

Having a relative or loved one receive a dementia diagnosis can be challenging for families, especially for families with children. How can parents, guardians and other adults explain these complex memory and thinking changes to children in a way they’ll understand? One possible way – children’s books. Dr. Tomás León joins the podcast to discuss his collection of children’s books focused on different kinds of dementia, including Alzheimer’s disease, frontotemporal dementia, Lewy body dementia and vascular dementia. He discusses his inspiration for the four stories, the writing and translation process, and the importance of helping children understand what’s happening to their loved ones, as well as shares advice on how to address these difficult conversations. Guest: Tomás León, MD, psychiatrist, Memory and Neuropsychiatry Clinic, Hospital del Salvador, Atlantic Fellow for Equity in Brain Health, Global Brain Health Institute (GBHI) Show Notes Read more about Dr. León’s children’s books and download copies of

The Research Education Component (REC) focuses on educating, mentoring and training the next generation of researchers at the over 30 Alzheimer’s Disease Research Centers (ADRCs) across the United States, offering a range of fellowships, educational activities and events like the annual Alzheimer’s Disease and Related Dementias (ADRD) Research Day. In honor of this year’s ADRD Research Day, early career researchers Isa Hayde and Dr. Yang Yeh join the podcast to discuss how REC has impacted their research journeys, as well as share a preview of their lightning presentations. Guests: Isa Hayde, undergraduate student, Clark Lab, and Yang Yeh, PhD, postdoctoral fellow, Lamming Lab Show Notes Learn more about REC and the Wisconsin ADRC’s Alzheimer’s Disease and Related Dementias Research Day on our website. Listen to the podcast with Drs. Barb Bendlin and Tyler Ulland, “Gut Feelings: The Links Between Gut Health and Alzheimer’s Disease,” mentioned by Dr. Chin at 5:30, on our website, Spotify, Apple Podcasts and al

Early detection is a top priority in the field of Alzheimer’s research, and one indicator of Alzheimer’s disease is the buildup of tau in the brain. What is tau, though? How can we detect this protein, and what can it tell us about a person’s symptoms or disease progression? Dr. Gil Rabinovici, a leader in the field of brain imaging, joins Dementia Matters this week for an in-depth discussion on the role of tau PET scans in Alzheimer’s disease detection, research and clinical care. Guest: Gil Rabinovici, MD, professor, Department of Neurology, University of California San Francisco (UCSF), director, UCSF Alzheimer’s Disease Research Center, study chair, Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) and New IDEAS studies, co-principal investigator, Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), Longitudinal Evaluation of Alzheimer’s Disease Study (LEADS) Show Notes Are you a clinician interested in receiving continuing education (CE) credits for listening to this episode? Find credit des

Receiving a diagnosis of Alzheimer’s disease or a related dementia can be a complicated experience. While some experience relief at being able to put a name to their concerns, many worry about telling loved ones or being treated differently due to the stigma surrounding the word “dementia.” Mike Zuendel joins the podcast to share his experience of being diagnosed with Mild Cognitive Impairment (MCI) due to Alzheimer’s disease and how he’s pushing back against the stigma surrounding dementia. He also talks about how early detection and treatment have allowed him to lead a normal life with cognitive impairment. Guest: Mike Zuendel, member, board of directors, Banner Alzheimer’s Institute Foundation, member, Alzheimer’s Patient Advisory Board, Center for Information and Study on Clinical Research Participation, founder, Initiative to Change the D-Word, founder, CEO, Legacy Bridge Private Family Offices Show Notes Learn more about Mike Zuendel on his profile on the Initiative to Change the D-Word’s website. Learn

Holistic medicine, alternative medicine, complementary medicine – you may have heard these terms or seen them used online and wondered what they mean. Each term refers to the concept of integrative medicine, a comprehensive approach to healthcare that focuses on treating a person’s mind, body and spirit rather than addressing symptoms or a specific disease through a combination of medical treatments and other evidence-based therapies. By integrating practices like nutrition, mindfulness, supplements and other alternative therapies with traditional care, integrative medicine aims to promote overall wellness, enhance healing and improve quality of life, especially for individuals managing chronic conditions like dementia. Dr. David Rakel, a leader in integrative medicine, joins the podcast to share about how this holistic approach can help people experiencing memory change and how diet, mindset and lifestyle can play a crucial role in supporting brain health.  Guest: David Rakel, MD, professor, chair, Universit

Caring for a loved one with Alzheimer’s disease or a related dementia can be challenging, with no two journeys being the same. Who better to turn to for caregiving support, tips and advice, then, than other caregivers who have been on similar paths? Steve O’Leary and Virginia Naeve join Dementia Matters to share their different experiences caring for their partner and parent respectively, their goal to help other caregivers on their journeys through their podcast Spotlight on Care and more. Guests: Steve O’Leary, co-host, Spotlight on Care, member, leadership council, University of California, Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), and Virginia Naeve, co-host, Spotlight on Care, volunteer, UCI MIND Show Notes Listen to the Spotlight on Care podcast on the UCI MIND website, Apple Podcasts, Spotify or wherever you listen to podcasts. Read Virginia’s blog, A New Path for Mom, online. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementia

Dementia diagnoses affect families in many different ways. One of the most challenging to navigate is that of younger-onset dementia (YOD), a form of dementia that affects someone below the age of 65. This diagnosis can be particularly jarring for young families, as resources, support and research for this form of dementia are limited. When Diana Cose’s husband Lorenzo received this diagnosis, she decided to change that by founding Lorenzo’s House, a nonprofit that supports families grappling with younger-onset dementia and works toward lessening the stigma surrounding it. Diana Cose joins the podcast with programs lead Patti LeFleur to share their experiences with younger-onset dementia and how Lorenzo’s House brings light in the darkness. Guests: Diana Cose, founding executive director, Lorenzo’s House, Patti LeFleur, youth and lighthouse outreach lead, Lorenzo’s House Show Notes Learn more about Lorenzo’s House and their free programs on their website. Follow Lorenzo’s House on their Instagram, Facebook an

What exactly does a mild cognitive impairment (MCI) diagnosis mean, and what should you do after receiving one? Hearing this diagnosis from a doctor can bring up a lot of emotions and questions for individuals and family members. Jennifer McAlister joins Dementia Matters to offer advice for next steps after receiving an MCI diagnosis and share strategies and resources that have been successful for individuals she’s worked with over the course of her career. Guest: Jennifer McAlister, outreach and partnerships manager, Outreach, Recruitment & Engagement Core, Wisconsin Alzheimer’s Disease Research Center   Show Notes Find Jen’s “Next Steps After Diagnosis” flowchart, mentioned at 41:22, on our website and as a PDF. View and download a PDF of the decision-making tool, mentioned at 28:57, online. Learn more about the Wisconsin ADRC’s Healthy Living with Mild Cognitive Impairment (MCI) series on our website. Watch the Healthy Living with MCI series on YouTube. Learn more about MCI by listening to our past pod

While there are many kinds of dementia, like Alzheimer’s disease and Lewy body dementia, there’s one that researchers have only recently identified. LATE, or Limbic-predominant Age-related TDP-43 Encephalopathy, is a newly-characterized type of dementia associated with abnormal clumps of a protein called TDP-43. So, what exactly do we know about LATE? Dr. David Wolk joins the podcast to share what key features of LATE are, how it compares to Alzheimer’s disease and impacts treatment, and what next steps are needed to better understand this neurodegenerative disease. Guest: David Wolk, MD, director, Penn Alzheimer’s Disease Research Center, co-director, Penn Memory Center, co-director, Penn Institute on Aging, chief, Division of Cognitive Neurology, professor of neurology, University of Pennsylvania Perelman School of Medicine Show Notes Learn more about LATE on the National Institute on Aging’s website and on Penn Memory Center’s website. Read Dr. Wolk's article, "Clinical criteria for limbic-predominant age-

The holidays can be a stressful time for everyone, especially those with dementia and their care partners. In preparation for this season, Dr. Alexis Eastman joins Dementia Matters for our last episode of 2024. Drs. Chin and Eastman discuss strategies for managing the potential stress of holiday traveling and gatherings, important safety considerations and more. Guest: Alexis Eastman, MD, geriatrician, Senior Medical Director of Ambulatory Medical Specialties, UW Health, associate clinical professor, Division of Geriatrics and Gerontology, University of Wisconsin School of Medicine and Public Health Show Notes Listen to our past episode with Dr. Eastman, “Holiday Tips for Dementia Caregivers,” on our website. Find more resources and tips for the holidays in “Resources for navigating the holidays with Alzheimer’s” on our website. Want to support Dementia Matters? Make an end-of-year gift to the Dementia Matters fund through the UW Initiative to End Alzheimer’s. Connect with us Find transcripts and more at our

With the recent surge in artificial intelligence and machine learning technology, one of the most exciting fields it could revolutionize is health care and, more specifically, the field of cognitive care and research. Dr. Marina Sirota and Alice Tang join the podcast to share their research on how AI could be used to predict one’s risk of developing Alzheimer’s disease based on their electronic health records. They also discuss what needs to be done to improve these algorithms and other ways this technology could be used in Alzheimer's disease research. Guests: Marina Sirota, PhD, associate professor, University of California San Francisco (UCSF), principal investigator, Sirota Lab, and Alice Tang, MD/PhD student, University of California San Francisco, postdoctoral fellow, Sirota Lab Show Notes Read Alice Tang and Dr. Sirota’s study, “Leveraging electronic health records and knowledge networks for Alzheimer’s disease prediction and sex-specific biological insights,” online through the journal Nature.. Learn